Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Oct 21, 2009

Exact Sciences Fortifies Position in Stool-Based DNA Detection Through Deal with Hologic

  • Exact Sciences obtained a worldwide license for Hologic’s Invader, Invader plus, and real-time Invader detection chemistries for use in colorectal cancer screening. The Invader chemistry is an accurate, easy-to-use, and rapid molecular detection platform that can be combined with PCR, according to Hologic. Exact anticipates coupling the digital PCR technology it has exclusively licensed from Johns Hopkins University with the quantitative detection capabilities of the Invader chemistry.

    Exact states that this deal reinforces its stronghold in the stool-based DNA, or sDNA, screening market. The company’s IP portfolio now includes exclusive licenses to key detection technologies, sDNA testing methods, and important biomarkers, it adds.



Related content

Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »